How Not 'Awesome' Was Lisa Jackson at the EPA?

After almost four years of guiding controversial decisions on fracking, the Keystone XL pipeline, and coal, EPA Administrator Lisa Jackson is stepping down. Now, the hunt is on for a new director who won't be able to please anyone.
RELATED: EPA Passes New Fracking Rules
Jackson—the EPA's first African American chief and a chemical engineer by training—wrote in a statement, "I will leave the EPA confident the ship is sailing in the right direction, and ready in my own life for new challenges, time with my family and new opportunities to make a difference." President Obama said in a separate statement:
Under her leadership, the EPA has taken sensible and important steps to protect the air we breathe and the water we drink, including implementing the first national standard for harmful mercury pollution, taking important action to combat climate change under the Clean Air Act and playing a key role in establishing historic fuel economy standards that will save the average American family thousands of dollars at the pump, while also slashing carbon pollution.
Congressional Republicans, however, won't be sad to see her go. Caught between their hostility toward regulation and the Obama administration's lack of emphasis on climate change, Jackson was unable to nix the Keystone XL oil pipeline, a planned route for bringing tar sand oil from Canada down to Texas. When confronted on the issue, Jackson simply said that holding conversations about the project is "awesome." She also wasn't able to get the EPA to take meaningful action on hydraulic fracturing, even after the agency found evidence that the practice contributes to groundwater pollution.
RELATED: EPA Proposes First Fracking-Related Pollution Rules
Among her successes, Jackson can count a rule limiting mercury emissions in coal-fired plants and the doubling of fuel efficiency standards. It remains to be seen whether the EPA's deputy administrator Robert Perciasepe—who looks prepped to take the reigns in the interim and potentially as full-time Administrator later on—can do any better.
Read More..

Website helps Dutch Catholics "de-baptize" over gay marriage

 Thousands of Dutch Catholics are researching how they can leave the church in protest at its opposition to gay marriage, according to the creator of a website aimed at helping them find the information.
Tom Roes, whose website allows people to download the documents needed to leave the church, said traffic on ontdopen.nl - "de-baptise.nl" - had soared from about 10 visits a day to more than 10,000 after Pope Benedict's latest denunciation of gay marriage this month.
"Of course it's not possible to be 'de-baptized' because a baptism is an event, but this way people can unsubscribe or de-register themselves as Catholics," Roes told Reuters.
He said he did not know how many visitors to the site actually go ahead and leave the church.
About 28 percent of the population in the Netherlands is Catholic and 18 percent is Protestant, while a much larger proportion - roughly 44 percent - is not religious, according to official statistics.
The country is famous for its liberal attitudes, for example to drugs and prostitution, and in April 2001 it was the first in the world to legalize same-sex marriages.
In a Christmas address to Vatican officials, the pope signaled the he was ready to forge alliances with other religions against gay marriage, saying the family was threatened "to its foundations" by attempts to change its "true structure".
Roes, a television director, said he left the church and set up his website partly because he was angry about the way the church downplayed or covered-up sexual abuse in Catholic orphanages, boarding schools and seminaries.
A report by an independent commission published a year ago said there had been tens of thousands of victims of child sexual abuse in the Netherlands since 1945 and criticized the church's culture of silence.
Read More..

Apple still said to account for 87% of North American tablet traffic as Kindle Fire, Nexus 7 gain

Apple’s (AAPL) share of the global tablet market is in decline now that low-cost Android slates are proliferating, but the iPad still appears to be the most used tablet by a huge margin. Ad firm Chitika regularly monitors tablet traffic in the United States and Canada and in its latest report, Apple’s iPad was responsible for almost 90% of all tablet traffic across the company’s massive network.
[More from BGR: Samsung looks to address its biggest weakness in 2013]
Using a sample of tens of millions of impressions served to tablets between December 8th and December 14th this year, Chitika determined that various iPad models collectively accounted for 87% of tablet traffic in North America. That figure is down a point from the prior month but still represents a commanding lead in the space.
[More from BGR: New purported BlackBerry Z10 specs emerge: 1.5GHz processor, 2GB RAM, 8MP camera]
The next closest device line, Amazon’s (AMZN) Kindle Fire tablet family, had a 4.25% share of tablet traffic during that period, up from 3.57% in November. Samsung’s (005930) Galaxy tablets made up 2.65% of traffic, up from 2.36%, and Google’s (GOOG) Nexus 7 and Nexus 10 tablets combined to account for 1.06% of tablet traffic in early December.
“Despite these gains by some of the bigger players in the tablet marketplace, there has been a negligible impact to Apple’s dominant usage share,” Chitika wrote in a post on its blog.
Read More..

Apple CEO gets modest 2012 pay after big 2011

 Apple CEO Tim Cook got $4.2 million in pay for the latest fiscal year, a modest sum compared with last year, when the company's board set him up with stock now worth $510 million for taking the reins in 2011.
Cook's pay for fiscal 2012, which ended in September, consisted of $1.4 million in salary, a bonus of $2.8 million, and $17,000 in company contributions to his 401(k) account and life insurance premiums, according to a filing.
Apple Inc.'s board saw no need to give Cook additional shares in 2012 after the sign-on grant of 1 million shares in 2011. Half of those shares vest in 2016 and the other half in 2021. A lot could happen to the value of the shares before Cook can cash them out, but the sign-on grant made him —at least on paper— the highest-paid U.S. CEO in 2011.
Cook did vest into shares worth $140 million in 2012. Those shares were granted earlier, when he was chief operating officer. He had been acting CEO for a while before the death of company co-founder Steve Jobs in October of 2011.
Apple tends to grant shares to executives every other year. Cook's closest cohorts got big grants in 2012, including top hardware engineer Robert Mansfield, who got shares worth $83 million. Chief Financial Officer Peter Oppenheimer and general counsel Bruce Sewell both got stock grants worth just over $66 million, more than double the value of the grants they got two years ago, reflecting the zooming value of Apple's stock.
The Cupertino, Calif.-based company's compensation policies are relatively simple. Missing are many of the perks that other CEOs command, like country club fees and private use of company aircraft.
Read More..

Toshiba’s new Lytro-like mobile image sensor could revolutionize smartphone photography

Cramming more megapixels into a smartphone with the thickness of a pencil is not the future of mobile picture-taking. Smartphones have hit a threshold where 8-megapixels is more than enough for taking crisp still shots and 1080p HD video. Many smartphones even perform decent under low-light conditions. But according to the Asahi Shimbun, Toshiba (TOSBF) has a new camera module that could change the way we take photos on smartphones anda tablets, forever.
[More from BGR: Samsung looks to address its biggest weakness in 2013]
Toshiba is reportedly shopping around an image sensor with Lytro-like capabilities, where the point of focus can be adjusted after the picture has been taken. To boil it down: the camera takes 500,000 small images, each with a different area in focus, and then combines them into a large photo where the focus can be changed later. The module is also capable of doing the same for videos.
[More from BGR: Google names 12 best Android apps of 2012]
The company is reportedly planning to sell the camera module “by the end of fiscal 2013″ and is looking to gather interest from other mobile device makers to implement it into smartphones and tablets.
Read More..

Discover Financial Services 4Q net income rises

 Discover Financial Services on Thursday reported higher earnings for its fiscal fourth quarter, as users of its namesake credit card stepped up purchases and the company wrote off fewer unpaid balances.
Even so, the Riverwoods, Ill.-based company's results fell short of Wall Street expectations, and investors sent its shares down over 3 percent Thursday.
Discover, the nation's sixth-largest credit card issuer, said total loans, credit card loans and Discover card sales volume increased 6 percent in the quarter, which coincided with the tail end of the back-to-school shopping season and the ramp up to the December holidays — key periods when consumers traditionally spend more.
Discover card sales volume increased to $26.5 billion, while credit card loans at the end of the quarter totaled $49.6 billion. Private student loans rose 6 percent, while personal loans climbed 24 percent, the company said.
"Our strong receivables and sales growth results demonstrate the effectiveness of our marketing programs, consumers' preference for cash rewards and our acceptance and awareness initiatives," Chairman and CEO David Nelms said during a conference call with analysts.
While Discover's customers racked up more debt, more of them paid off credit card balances on time. The delinquency rate on credit-card loans over 30 days past due was 1.86 percent, an improvement of 53 basis points from a year earlier. The rate of charge-offs, when the company writes off unpaid credit card balances, dropped to a historic low of 2.29 percent.
"While the continued improvement in credit appears to be nearing an end, we don't believe we are at a point where charge-offs are poised to rise significantly," Nelms said.
Nationwide the rate of credit card payments at least 90 days overdue edged up in the third quarter to 0.75 percent, according to credit reporting agency TransUnion. The rate is coming off historically low levels, however.
Discover has traditionally had one of the lowest rates for default and delinquency in the credit card industry, the result of tighter lending standards and close monitoring of problem accounts.
The company has reported improvement in its customers' default and late-payment rates since the Great Recession, as cardholders moved to pay down debt and boost savings.
Late-payment rates tend to creep higher in the fall, particularly as cardholders spend more money on holiday shopping, travel and other expenses. The company said that seasonal factor led to a slight increase in its credit card loan delinquency rate between the third and fourth quarter.
While Discover's rates for late payments and defaults remain low, the company has been making more loans. As a result, it has been setting aside more funds to cover potential loan losses.
In the September-to-November quarter, Discover increased its provision for loan losses by 6 percent to $338 million, noting that was somewhat offset by a drop in the number of unpaid credit card balances that had to be written off.
Meanwhile Discover's payment-services business, which competes with Visa and MasterCard, saw dollar volume increase 13 percent in the latest quarter.
In a client note Thursday, RBC Capital Markets analyst Jason Arnold said Discover is benefiting from increased acceptance of its cards and favorable credit trends.
"We remain very enthused by Discover's fundamental position and believe the company remains well positioned for loan and (earnings per share) growth," wrote Arnold, who has a $50 price target on the stock.
For the period ended Nov. 30, Discover earned $541 million, or $1.07 per share. That compares with $513 million, or 95 cents per share, a year earlier.
Analysts surveyed by FactSet expected earnings of $1.12 per share.
Revenue climbed 11 percent to $2 billion, after interest expense. Wall Street forecast $1.96 billion.
Also on Thursday, Discover declared a dividend of 14 cents per share. It will be paid on Jan. 17 to shareholders of record on Jan. 3.
Discover shares fell $1.36, or 3.4 percent, to close at $38.41 Thursday. The stock is up 60 percent this year.
Read More..

RIM shares fall at the open after earnings

 Research In Motion Ltd fell in early trading on Friday following the BlackBerry maker's Thursday earnings announcement, when the company outlined plans to change the way it charges for services.
RIM, pushing to revive its fortunes with the launch of its new BlackBerry 10 devices next month, surprised investors when it said it plans to alter its service revenue model, a move that could put the high-margin business under pressure.
Shares fell 16.0 percent to $11.86 in early trading on the Nasdaq. Toronto-listed shares fell 15.8 percent to C$11.74.
Read More..

Walgreen fiscal 1Q profit sinks nearly 26 pct

fiscal first-quarter earnings sank nearly 26 percent as costs tied to a couple big deals and Superstorm Sandy helped put a bigger-than-expected dent in the drugstore chain's performance.
CEO Greg Wasson told analysts he saw the quarter as a "turning point" for the Deerfield, Ill., company, which has been working to recapture customers it lost during a contract dispute with Express Scripts Holding Co. But investors didn't buy that message at least initially, as the stock fell deeper than broader market declines in Friday trading.
Walgreen Co. spent $4 billion in cash earlier this year to buy a stake in Alliance Boots, a Swiss company that runs the largest drugstore chain in the United Kingdom. It also spent $438 million on a drugstore chain focused on the mid-South under the USA Drug, Super D Drug and Med-X names.
Costs tied to those deals totaled $23 million in the quarter, and Walgreen said it only counted a small portion of the gains it received from Alliance Boots. It is reporting those gains a quarter after they occur to address audit and regulatory requirements.
The storm system that swept up the East Coast in late October also cost $24 million in the quarter, as it forced Walgreen to temporarily close hundreds of stores.
Overall, Walgreen earned $413 million, or 43 cents per share, in the three months that ended Nov. 30. That compares with net income of $554 million, or 63 cents per share, a year ago. Walgreen said earlier this month revenue fell nearly 5 percent to $17.34 billion.
Excluding one-time costs, adjusted earnings were 58 cents per share.
Analysts forecast, on average, earnings of 70 cents per share, according to FactSet.
Shares dropped 3.3 percent, or $1.24, to close at $36.31 Friday, while the Standard & Poor's 500 index fell 1 percent.
Walgreen runs more than 8,000 drugstores in all 50 states as the nation's largest drugstore chain. The company's revenue has slumped through 2012 after it started the year stuck in a contract squabble with Express Scripts, for which it fills prescriptions.
The companies had let a contract between them expire last December, and their new agreement didn't start until September. The split meant many Express Scripts customers migrated to new drugstores for their prescriptions.
Walgreen is trying to bring those customers back, but competitors like CVS Caremark Corp. and Rite Aid Corp. are pushing aggressively to keep them.
Walgreen said prescriptions filled at stores open at least a year fell nearly 5 percent in the quarter, a smaller decrease than the 8 percent drop it reported in the previous quarter. The drugstore chain saw that improvement as a sign that customers are returning.
"We think we can redeem significant portion of these customers over time," Wasson said.
Walgreen said prescription revenue from stores open at least a year fell 11.3 percent, while revenue from the front end, or rest of the store, dropped 2 percent. Revenue from stores open at least a year is considered a key indicator of retailer health because it excludes stores that recently opened or closed.
Generic drugs have squeezed revenue for Walgreen and other drugstores this year because they are cheaper than brand-name drugs. But they help profitability because they come with a wider margin between the cost for the pharmacy to purchase the drugs and the reimbursement it receives.
Walgreen launched a customer loyalty program called Balance Rewards during the quarter. It allows shoppers to gain points at both Walgreen and Duane Reade stores and for online purchases that translate into cash rewards they can then use at the stores.
Walgreen executives said the program will encourage customers to visit their stores more frequently and to buy more.
Read More..

Nigeria's Dangote Cement expects 38 pct rise in Q1 profit

Nigeria's biggest listed company, Dangote Cement, expects pretax profit to rise 38.9 percent year-on-year to 42.09 billion naira in the first three months of next year, it said in a filing with the Nigerian Stock Exchange.
Dangote Cement, Nigeria's biggest cement producer, said it expected turnover of around 81.6 billion naira in the first quarter, compared with 64.1 billion naira it achieved in the same period in 2012.
The company which is majority owned by billionaire tycoon Aliko Dangote earlier this month shut down a fifth of its production capacity because of a glut in the market caused by imported cement from Asia.
It is yet to release its 2012 full year results.
Read More..

Piano maker Steinway takes down 'for sale' sign

 Steinway Musical Instruments Inc, the famous manufacturer of pianos, saxophones and trumpets, said on Wednesday it had decided not to sell itself following a 17-month-long exploration of strategic alternatives.
An American icon synonymous with handmade grand pianos, Steinway has struggled to keep its production margins competitive amid stagnant sales, and has seen its shares plunge 10 percent year-to-date. Still, its third-quarter earnings last month offered signs that cost-cutting was paying off.
In a statement on Wednesday, Steinway said it had received several non-binding indications of interest in buying the company, following talks with other companies in the sector as well as private equity, yet these did not offer more value than its own strategic plan.
"We will continue to focus management's efforts on execution of that plan and we look forward to a prosperous 2013," Steinway CEO Michael Sweeney said in the statement.
An in-principle agreement to sell its band instrument division to an investor group led by two of its board members, Dana Messina and John Stoner, was also scrapped in light of the current operating performance of the band division, Steinway said.
In July 2011, Messina, Stoner and other members of management made an offer for Steinway's band instrument and online music divisions, prompting the company to set up a special committee in order to assess it.
Later that month, Steinway asked investment bank Allen & Company LLC to a assist the special committee on exploring strategic alternatives that could also include selling the whole company outright to other interested parties.
By October 2011, Messina had stepped down as CEO of the company after 15 years at the helm to pursue his bid, yet he remained a board member. He was replaced by Sweeney, a chairman of the board of Star Tribune Media Holdings and a former president of Starbucks Coffee Company (UK) Ltd.
Steinway said on Wednesday that it was continuing a separate process to sell its leasehold interest in New York's Steinway Hall building, situated on Manhattan's 57th Street, and was in talks with several parties.
According to its website, Steinway & Sons, the company's piano unit, opened the first Steinway Hall on 14th Street in Manhattan in 1866.
With a main auditorium of 2,000 seats, it became New York City's artistic and cultural center, housing the New York Philharmonic until Carnegie Hall opened in 1891. These days, Steinway Hall is a showroom for the company's instruments.
The Waltham, Massachusetts-based company's pianos have been used by legendary artists such as Cole Porter and Sergei Rachmaninoff and by contemporary ones like Chinese concert pianist Lang Lang.
Read More..

Duke still No. 1 in AP poll; Pitt, K-State move in

Duke and Michigan remain the top two teams in The Associated Press' college basketball poll while Syracuse drops from third to ninth after its first loss.
The Blue Devils received all but two of the first-place votes Monday from the 65-member national media panel. Michigan got the others.
Arizona, Louisville and Indiana all moved up one place to third through fifth. Kansas, which won at Ohio State, moved from ninth to sixth. Missouri, which beat Illinois, jumped from 12th to seventh. Cincinnati advanced from 11th to eighth. Syracuse, which lost to Temple, and Ohio State complete the top 10.
Pittsburgh and Kansas State are the newcomers to the poll at 24th and 25th. They replace New Mexico and North Carolina, which dropped out from 16th and 23rd after losses to South Dakota State and Texas.
Read More..

Playoff puzzle nearly complete with one week to go

With one week remaining in the regular season, the National Football League's playoff picture has come into sharper focus with only a few more pieces of the post-season puzzle to be put into place.
Much of the remaining drama is focused on the NFC East, where the Washington Redskins, Dallas Cowboys and New York Giants will stage a battle royale for the division crown with a ticket to the post-season going to the survivor.
The Redskins (9-6), riding a six-game winning streak and with rookie sensation quarterback Robert Griffin III healthy and calling plays, host the Cowboys (8-7) in the Sunday evening prime time finale to the NFL regular season that will see the winner claim the division.
While the Cowboys' (8-7) only path to the post-season requires a victory, the Redskins could still scrape into the playoffs with a loss if the Chicago Bears and Minnesota Vikings also lose their finales.
The situation is much more dire for the slumping Giants (8-7), who will need plenty of help to advance.
The defending Super Bowl champions have lost five of their last seven and must defeat the Philadelphia Eagles at home on Sunday and hope Dallas, Chicago and Minnesota all lose.
TRIP TO MOTOR CITY
The Seattle Seahawks (10-5) and San Francisco 49ers (10-4-1) enter the final weekend having clinched playoff berths but with the NFC West title still up for grabs along with a possible first round bye.
San Francisco can take top spot in the West with a win at home over the Arizona Cardinals (5-10) while the surging Seahawks, who have outscored opponents 150-30 in their last three contests, must close out the regular season with a fifth straight victory when they visit the St. Louis Rams (7-7-1) and have the 49ers lose.
With the 49ers or Seahawks guaranteed playoff spots the other NFC wildcard will go to either the Bears (9-6) or Vikings (9-6).
The Vikings, who have staged a late season charge behind the running of Adrian Peterson, can lock up a playoff spot with visit to Lambeau Field and a win over NFC North rivals the Green Bay Packers (11-4).
The Bears close out the campaign with a trip to the Motor City where they must combine victory over the Lions (4-11), losers of seven straight with a Vikings loss to move on.
The Atlanta Falcons (13-2) clinched a first round bye and home field advantage throughout the playoffs with a 31-18 win over the Detroit Lions on Saturday and the Packers can also grab a first round bye with a win over Minnesota or a San Francisco loss combined with a Seattle loss or tie.
The post-season picture is much clearer in the AFC with the four division winners, New England Patriots (East), Baltimore Ravens (North), Houston Texans (South), Denver Broncos (West) and wildcards Cincinnati Bengals and Indianapolis Colts already decided.
The Broncos (12-3), Texans (12-3) and Patriots (11-4), however, will all have something to play for on the final Sunday with two first round byes and home field advantage throughout the playoffs on offer.
Denver, who will host the Kansas City Chiefs (2-13) and Houston, who visit the Colts can get the first weekend off with wins while the Patriots must beat the Miami Dolphins (7-8) and have either the Broncos or Texans lose.
A number of combinations of wins and losses could give the Texans, Broncos or Patriots home field advantage for the playoff run.
Read More..

AP source: Dolphins' Smith has knee bruise

A person familiar with the diagnosis says Miami Dolphins cornerback Sean Smith escaped serious injury when he hurt his left knee in the team's victory over Buffalo.
An MRI test Monday determined the injury was only a bruise, the person told The Associated Press, speaking on condition of anonymity because the Dolphins are not releasing details about the injury.
Smith, a fourth-year pro and Miami's best cornerback, can become a free agent this offseason. The Dolphins, who are out of the playoff race, conclude the season Sunday at New England.
Read More..

Pagano back to coach Colts after cancer treatment

 Chuck Pagano stepped to the podium Monday, hugged his team owner, thanked his family for its support and wiped a tear from his eye.
He might, finally, turn out the lights in his office, too.
Nearly three months to the day after being diagnosed with leukemia, the Colts' first-year coach returned to a team eager to reunite with a boss healthy enough to go back to work.
"I told you my best day of my life was July 1, 1989," Pagano said, referring to his wedding date. "Today was No. 2. Getting to pull up, drive in, get out of my car, the key fob still worked. I was beginning to question whether it would or not. When I asked for Bruce to take over, I asked for him to kick some you-know-what and to do great. Damn Bruce, you had to go and win nine games? Tough act to follow. Tough act to follow. Best in the history of the NFL. That's what I have to come back to."
The comment turned tears into the laughter everyone expected on such a festive occasion.
For Pagano and the Colts, Monday morning was as precious as anyone could have imagined when Pagano took an indefinite leave to face the biggest opponent of his life, cancer.
In his absence, all the Colts was win nine of 12 games, make a historic turnaround and clinch a playoff spot all before Sunday's regular-season finale against Houston, which they pegged as the day they hoped to have Pagano back. If all goes well at practice this week, Pagano will be on the sideline for the first time since a Week 3 loss to Jacksonville.
Pagano endured three rounds of chemotherapy to put his cancer in remission.
That Pagano's return came less than 24 hours after Indy (10-5) locked up the No. 5 seed in the AFC and the day before Christmas seemed fitting, too.
"I know Chuck is ready for this challenge. In speaking to his doctor multiple times, I know that the time is right for him to grab the reins, get the head coaching cap on and begin the journey," owner Jim Irsay said. "It's been a miraculous story. It really is a book. It's a fairytale. It's a Hollywood script. It's all those things but it's real."
The reality is that he's returning to a vastly different team than the one he turned over to Arians, his long-time friend and first assistant coaching hire.
Back then, the Colts were 1-2 and most of the so-called experts had written them off as one of the league's worst teams. Now, they're ready to show the football world that they can be just as successful under Pagano as they were under Arians, who tied the NFL record for wins after a midseason coaching change.
Pagano also has changed.
The neatly-trimmed salt-and-pepper hair and trademark goatee that were missing in November have slowly returned, and the thinner man who appeared to be catching his breath during a postgame speech in early November, looked and sounded as good as ever Monday.
He repeatedly thanked fans for their prayers and letters, the organization and his family for their unwavering help and promised to provide comfort and support to other people who are facing similar fights. During one poignant moment that nearly brought out tears again, Pagano even recounted a letter sent to him by a 9-year-old child who suggested he suck on ice chips and strawberry Popsicles in the hospital and advised him to be nice to the nurses regardless of how he felt — and he never even paused.
"I feel great, my weight is back, my energy is back and again, it's just a blessing to be back here," Pagano said.
In the minds of Colts players and coaches, Pagano never really left.
He continually watched practice tape and game film on his computer, used phone calls and text messages to regularly communicate with players and occasionally delivered a pregame or postgame speech to his team.
"He texted me and called me so much, it was like he was standing there in my face every day," said receiver Reggie Wayne, who has been friends with Pagano since the two were working together at the University of Miami.
But the Colts found plenty of other ways to keep Pagano's battle in the forefront.
They began a fundraising campaign for leukemia research, calling it Chuckstrong. Players had stickers with the initials CP on their locker room nameplates, and Arians wore an orange ribbon on his baseball cap during games. Orange is the symbolic color for leukemia. At one point, nearly three dozen players shaved their heads to show their ailing coach they were with him.
That's not all.
Arians and first-year general manager Ryan Grigson decided to leave the lights on in Pagano's office until he returned. Pagano noted the team even installed plastic clips to make sure those lights were not mistakenly turned off while he was gone. Those clips were removed when Pagano arrived Monday morning.
And Arians said nobody sat in the front seat of the team bus.
"He's always been our head coach," Arians said.
So after getting medical clearance from his oncologist, Dr. Larry Cripe, to return with no restrictions, Pagano couldn't wait to get to the office Monday morning.
Arians arrived at 7 a.m., three hours early for the scheduled team meeting. By then, Pagano had already driven past the inflatable Colts player with the words "Welcome Back Chuck" printed on its chest and was back in his office preparing for the Texans.
Players showed up a couple of hours later, and when the torch was passed from Arians back to Pagano, players gave their returning coach a standing ovation that Wayne said was well-deserved.
All Pagano wants to do now is emulate the success Arians and his players have had this season.
"I asked him (Arians) if he would lead this team and this ballclub and this organization and take over the reins," Pagano said. "What a masterful, masterful job you did Bruce. You carried the torch and all you went out and did was win nine ballgames. You got us our 10th win yesterday and you got us into the playoffs. You did it with dignity and you did it with class. You're everything that I always knew you were and more.
Read More..

Pagano joins playoff bound Colts after battle with cancer

The Indianapolis Colts and their fans got an early Christmas gift when head coach Chuck Pagano returned to work on Monday, three months after being forced to the sidelines to battle cancer.
Diagnosed with leukemia in late September, Pagano spent the last three months undergoing treatment, including chemotherapy, while his inspired team led by rookie quarterback Andrew Luck battled on the field earning an unlikely playoff spot.
"Circumstances don't make you, they reveal you," an emotional Pagano told reporters after reporting for work at the teams Indianapolis training facility. "The way I look at it is, my job has just begun.
"Besides my job here...my job now is to give back everything I can possibly give back to everyone out there who's fighting some type of illness, some type of disease, some type of cancer."
The Colts, who tied for the NFL's worst record last season at 2-14, improved to 10-5 with their win over the Kansas City Chiefs on Sunday clinching an AFC wild card.
After three games into a rebuilding season, the Colts learned Pagano would take indefinite leave to fight his cancer and was replaced by assistant coach and offensive coordinator Bruce Arians.
The goal of the Colts became to keep playing until Pagano could return to work.
Indianapolis went 9-3 under Arians, who will hand over the head coaching job back to Pagano for the regular season finale this Sunday against the Houston Texans.
"It's a fairy tale," said Colts owner Jim Irsay. "It's a Hollywood script. But it's real.
Read More..

Medical abortions are safe: study

- Less than one percent of women getting a medication-induced abortion at Planned Parenthood had a serious side effect or a failed abortion, according to a new study. Researchers found the rate of abortion-related complications sending women to the emergency room or requiring a blood transfusion, for example, was one in 625 during 2009 and 2010. "At Planned Parenthood, medical abortion is extremely safe," said reproductive health researcher James Trussell from Princeton University in New Jersey, who worked on the study. "The most common adverse outcome is just continuing pregnancy," he added. "It doesn't work 100 percent of the time." The data came from 233,805 first-trimester abortions done using the drugs mifepristone and misoprostol at 317 Planned Parenthood health centers. In one in 200 of those cases, women had an ongoing pregnancy that wasn't terminated after two attempts with medication, the researchers reported Thursday in Obstetrics & Gynecology. Eight women each year had an ectopic pregnancy - when the embryo implants outside the uterus - that was diagnosed after the attempted abortion. One died from related complications. Of the 233,805 abortions during the study period, 385 women had a serious side effect, including 238 who sought ER treatment, 135 who were admitted to the hospital, 114 who had a blood transfusion and 57 who required intravenous antibiotics. All of those women survived. "This continues to show that medical abortion is a very, very safe option for women," said Dr. Debra Stulberg, who studies disparities in reproductive health at the University of Chicago and wasn't involved in the new study. "That's really the take-home point." She told Reuters Health medical abortions are still less common than surgical ones in the U.S., but that they're becoming relatively more frequent and "women should be reassured" based on these and other data. Surgical procedures are also known to be safe, researchers noted. One study from 2010 found that about one percent of women having a surgical abortion before their 16th week of pregnancy had a complication that could require intravenous fluid, and just one in 300 had a major complication. One limitation, the study team noted, is that not all women checked back after the abortion or had follow up medical records available - so it's possible more complications could have occurred that weren't recorded. Planned Parenthood staff members were required to make three attempts to reach any patients who didn't return for follow up visits under the organization's medical standards and guidelines. "We assume that if anything had happened, that people would get back in touch with Planned Parenthood," Trussell told Reuters Health. "The reason that people often skip their follow up is, they're fine." Two of the study's authors are Planned Parenthood employees, and Trussell is a member of the National Medical Committee of Planned Parenthood Federation of America. Another author receives compensation from the U.S. distributor of mifepristone, Danco Laboratories. The medication regimen used by Planned Parenthood - and many other abortion providers - is slightly different than the U.S. Food and Drug Administration-approved drug course because it includes lower doses of mifepristone and at-home use of misoprostol. There have been attempts in some states to force providers to use the approved regimen, according to Trussell, even though so-called off-label use of the drugs is allowed. There's no evidence the FDA regimen is safer, he said - but it is more expensive. "It has nothing to do with medicine," he said. "It's just nuisance." Medical abortions done at Planned Parenthood run for about $300 to $800, according to its website. The researchers said their findings don't support laws restricting the drugs' use. "Mandating the FDA-approved regimen, without a scientific basis, does not protect patients from unsafe abortion; it only limits access to safe and effective medical abortion for women desiring a pregnancy termination," they concluded.
Read More..

U.S. food, animal groups seek lower ractopamine limits

Food safety and animal welfare groups petitioned the U.S. Food and Drug Administration on Thursday seeking limits on an animal feed additive that is the subject of concerns about human and animal health. Russia said earlier this month that it was requiring meat it imports to be tested and certified free of the feed additive ractopamine, a move jeopardizing the more than $500 million a year in exports of U.S. beef and pork to that country. U.S. trade authorities have taken a stand against Russia's sudden decision to require that meat imports be documented as free of ractopamine and have urged Russia to suspend such measures. Russia has denied that its action on meat imports was in response to the U.S. Senate including a measure to "name and shame" human rights violators as part of a bill expanding trade with Russia. Ractopamine is fed to animals to accelerate growth and make their meat leaner, but countries such as China have banned its use amid concerns the additive may be harmful to the animals and that traces of the drug could persist in meat products. In their petition to the FDA, the Center for Food Safety and the Animal Legal Defense Fund called for an immediate reduction in the allowable levels of ractopamine and asked FDA to study the long-term effect of human consumption and the impacts on animals associated with ractopamine. "FDA's approval for ractopamine relied primarily on safety studies conducted by the drug-maker, Elanco," the groups said in a statement. "A review of available evidence collected from FDA and the European Food Safety Authority calls FDA's approvals into question." The groups said that ractopamine is fed to an estimated 60 to 80 percent of U.S. pigs, and has resulted in more reports of sickened or dead pigs than any other livestock drug on the market. Ractopamine effects may include toxicity and other exposure risks, such as behavioral changes and cardiovascular, musculoskeletal, reproductive, and endocrine problems, the groups said. About 160 countries ban or restrict ractopamine, including all the nations of the European Union, China, Taiwan, and Russia, the groups said. FDA spokeswoman Shelly Burgess said the agency had extensively evaluated ractopamine before approval and "continues to monitor the safety and effectiveness of animal drugs like ractopamine" after they receive FDA approval. "Twenty-six other countries have also approved ractopamine," Burgess said. All of these countries ... have concluded that food derived from animals treated with ractopamine is safe for humans to eat.
Read More..

Enzon Pharma cuts more jobs, to stop drug development

Enzon Pharmaceuticals Inc said it will suspend all clinical development activities, days after the cancer drug developer decided to explore a possible sale. The company, in which activist investor Carl Icahn has a 13.29 percent stake, spent about $4 million last quarter on pipeline research and development and had cash, cash equivalents and marketable securities of $288.7 million as of September 30. It will also reduce its workforce from 43 employees to about 23-28, Enzon said. Last September, it laid off about half its workforce. The biotechnology company has two drugs in mid-stage trials and a number of others in early-stage studies. Enzon, whose revenue mainly comes from royalty payments, will incur about $1.4 million in charges related to the reduction in force and expects to record charges in the first quarter of 2013. Shares of Enzon, which has a market capitalization of about $200 million, closed at $4.50 on Thursday on the Nasdaq.
Read More..

Federal appeals court rules against Hobby Lobby on contraception

A federal appeals court on Thursday rejected a claim by an arts and crafts chain that wants to be exempted from a requirement to provide emergency contraceptives to employees because it violates the religious principles of its owners. The Court of Appeals in Denver ruled against family-owned Hobby Lobby's assertion that the religious beliefs of its owners should relieve them from providing the "morning after" and "week after" pills to their employees, as required under President Barack Obama's signature health care reforms. Hobby Lobby vowed to appeal to the U.S. Supreme Court. "The Green family is disappointed with this ruling," said Kyle Duncan, general counsel for the Becket Fund for Religious Liberty, which is assisting Hobby Lobby in the legal case. "The Greens will continue to make their case on appeal that this unconstitutional mandate infringes their right to earn a living while remaining true to their faith." The medications at issue are classified as emergency contraceptives by the Food and Drug Administration, but the owners of Hobby Lobby call them "abortion-inducing drugs" because they are often taken after conception. The lawsuit is among 42 legal actions that have been filed over the issue, according to the Becket Fund for Religious Liberty, a non-profit law firm in Washington, D.C. The company faces fines of up to $1.3 million daily if it disobeys the mandate, which takes effect on January 1 for Hobby Lobby, a $3 billion chain, and its smaller sister operation, Mardel, a Christian-oriented bookstore and educational supply company. Both companies are owned by the Green family of Oklahoma City, whose patriarch, David Green, is ranked 79th on Forbes Magazine's list of the 400 richest Americans, with a net worth of $4.5 billion. The family operates 514 Hobby Lobby stores in 41 states and employ 13,240 people. Inspirational Christian music is played in the stores, which are closed on Sundays. U.S. District Judge Joe Heaton of the Western District of Oklahoma ruled on November 19 that the privately-owned companies are secular, for-profit enterprises that do not possess the same religious rights as the individual members of the family.
Read More..

China probes Yum Brands' KFC over safety of chicken products

Yum Brands Inc's fast-food chain KFC was supplied with chicken in China that contained excessive amounts of antibiotics, said food safety authorities investigating allegations of tainted KFC products. The finding by the Shanghai Food and Drug Administration (SFDA) deals a blow to KFC's reputation in China, where it is facing fierce competition from the likes of Taiwanese-owned fried chicken chain Dico and Japanese-style noodle chain Ajisen (China) Holdings Ltd. Yum Brands has forecast a drop in same store China sales in the fourth quarter. Eight of the 19 batches of chicken samples Yum Brands sent to a testing laboratory in 2010 and 2011 contained overly high levels of antibiotics, the SFDA said in a statement on its Website late on Thursday. An investigation is underway to determine whether Yum Brands had taken corrective measures at that time, and the Louisville, Kentucky-based company may face harsh penalties if the probe showed laws had been violated, the SFDA said. Shares in Yum Brands have slumped 4 percent since December 18 when China's state television CCTV reported that some poultry suppliers in eastern Shandong province had fed chickens with anti-viral drugs and hormones to accelerate their growth. The SFDA is looking into the CCTV report and has not released its findings yet, but authorities in Shandong have already shut two chicken farms in eastern China, including one that supplied KFC and McDonald's Corp, the official Shanghai Daily newspaper reported on Thursday. Officials at Yum Brands in China could not be immediately reached for comment. KFC's subsidiary in China has pledged to cooperate with the authorities, while McDonald's wrote on its official microblog that its chicken and raw materials pass through independent, third-party laboratory tests. Shares in Yum Brands, which also owns Pizza Hut and Taco Bell, closed 1 percent lower at $69.49 in New York on Thursday. China has been trying to stamp out health violations that have dogged the country's food sector amid reports of fake cooking oil, tainted milk and even exploding watermelons. In 2008, milk laced with the industrial chemical melamine killed at least six children and sickened nearly 300,000.
Read More..

Reports: Rolling Stones guitarist Wood ties knot

Two British newspapers say Rolling Stones guitarist Ronnie Wood has married his fiancee Sally Humphreys at a ceremony at London's Dorchester Hotel. The Sun and the Daily Mirror carried photographs of the 65-year-old rocker with a pale boutonniere and a dark blue suit, and his 34-year-old bride in a traditional white gown and a clutch of matching white flowers. The Sun quoted Wood as saying "I'm feeling great" as he and his bride kissed and posed for pictures outside the exclusive hotel in London's upscale Mayfair district. The newspapers said the guests included singer Rod Stewart and his wife Penny Lancaster as well as ex-Beatle Paul McCartney and his wife Nancy Shevell. A call and an email to Wood's U.S.-based agent weren't immediately returned Saturday.
Read More..

Buju Banton awaits ruling in mistrial request

A Florida juror who voted to convict Jamaican reggae singer Buju Banton on drug charges has denied improperly researching the case during trial, in spite of a weekly newspaper's report that quoted her as saying that she did. Banton is serving a 10-year prison sentence on two drug charges. The Grammy winner faces an additional five years on a related gun possession charge, but his resentencing hearing was postponed to investigate the report of juror misconduct. Banton's attorneys have filed a motion in Tampa federal court seeking a new trial. If granted, it would be the second mistrial for Banton, whose first trial in 2010 ended with jurors deadlocked. He was convicted in 2011 in his second trial. U.S. District Judge James Moody reserved decision Thursday on the defense motion. Jurors were told during trial not to do any independent research into the case. Terri Wright, a juror from Banton's 2011 trial, was quoted in a Miami New Times report as saying that she researched parts of the case, in spite of the judge's orders not to. "I would get in the car, just write my notes down so I could remember, and I would come home and do the research," Wright was quoted as saying. New Times reporter Chris Sweeney testified Thursday that he interviewed several jurors. The Tampa Tribune reports (http://bit.ly/RLgxXO) that Sweeney provided the court with a recording of his interview with Wright. Wright testified that she sent Sweeney a text message after seeing his story, saying there had been "a huge misunderstanding with (Sweeney's) questions." Wright's text message also read, "I did not violate the judge's instructions with this case. I did my research AFTER the case was over and the verdict was given, NOT during the case. . I trusted you and now feel totally betrayed." Wright testified that she only researched Banton's music and the federal Pinkerton rule, which involves liability among conspirators for the actions of other conspirators. There was no proof that Banton possessed a gun or was aware that a co-defendant did, but because of the Pinkerton rule, Banton was convicted of a weapons offense. Moody tossed the gun charge, but an appeals court reversed that decision. Moody called a sampling of three other jurors to ask if they remembered hearing other jury members talk about doing outside research. Two testified that had not heard anything, but one said she recalled a white woman juror saying she had researched the Pinkerton law. Wright is black. Assistant U.S. Attorney James Preston said Banton's defense had not met the legal requirement for a mistrial by showing that the jury was exposed to outside evidence that posed a reasonable possibility of prejudice to the defendant. Defense lawyer Chokwe Lumumba said jurors were ready to acquit Banton, whose real name is Mark Myrie, before Wright shared her research.
Read More..

Reggae's Buju Banton awaits ruling on mistrial

A Florida juror who voted to convict Jamaican reggae singer Buju Banton on drug charges has denied improperly researching the case during trial, despite a weekly newspaper's report that quoted her as saying that she did. Banton is serving a 10-year prison sentence for his convictions on cocaine conspiracy and trafficking charges stemming from a 2009 arrest. The Grammy winner faces an additional five years for his conviction on a related gun possession charge, but his resentencing hearing was postponed to investigate the report of juror misconduct. Banton's attorneys have filed a motion in Tampa federal court seeking a new trial. If granted, it would be the second mistrial for Banton, whose first trial in 2010 ended with jurors deadlocked. He was convicted in 2011 in his second trial. U.S. District Judge James Moody reserved judgment Thursday on the defense motion. Jurors were told during the trial not to do any independent research into the case. Terri Wright, a juror from Banton's 2011 trial, was quoted in a Miami New Times report as saying that she researched parts of the case even though the judge had ordered jurors not to. "I would get in the car, just write my notes down so I could remember, and I would come home and do the research," Wright was quoted as saying. New Times reporter Chris Sweeney testified Thursday that he interviewed several jurors. Sweeney also provided the court with a recording of his interview with Wright. Wright testified that she sent Sweeney a text message after seeing his story, saying there had been "a huge misunderstanding with (Sweeney's) questions." Wright's text message also read, "I did not violate the judge's instructions with this case. I did my research AFTER the case was over and the verdict was given, NOT during the case. . I trusted you and now feel totally betrayed." Wright testified that she only researched Banton's music and the federal Pinkerton rule, which involves liability among conspirators for the actions of other conspirators. There was no proof that Banton possessed a gun or was aware that a co-defendant did, but because of the Pinkerton rule, Banton was convicted of a weapons offense. Moody tossed the gun charge, but an appeals court reversed that decision. Wright said she told Sweeney that she had been a juror seven times before serving on Banton's case, but she did not volunteer that information to prosecutors or Banton's attorneys "because that wasn't a question" during jury selection. Moody called a sampling of three other jurors to ask if they remembered hearing other jury members talk about doing outside research. Two testified that had not heard anything, but one said she recalled a white female juror saying she had researched the Pinkerton law. Wright is black. Assistant U.S. Attorney James Preston said Banton's defense had not met the legal requirement for a mistrial by showing that the jury was exposed to outside evidence that posed a reasonable possibility of prejudice to the defendant. Defense lawyer Chokwe Lumumba said jurors were ready to acquit Banton, whose real name is Mark Myrie, before Wright shared her research.
Read More..

Swedish princess to marry next June

STOCKHOLM (AP) — Sweden's royal family says Princess Madeleine's wedding will take place on Saturday, June 8, at the Royal Palace chapel in downtown Stockholm. King Carl XVI Gustaf and Queen Silvia's youngest daughter was engaged to U.S.-British boyfriend Christopher O'Neill, a 38-year-old New York banker, in late October. The 30-year-old Madeleine is fourth in line to the Swedish throne. The royal family's chief spokesman Bertil Tenert said Sunday that wedding organizers will now start planning details of the nuptials. He added that Madeleine's wedding will be smaller than Crown Princess Victoria's wedding two years ago in Stockholm. The Swedish royal family has only ceremonial duties, such as supporting charities and promoting Swedish businesses.
Read More..

Rihanna donates $1.75 million to Barbados hospital

BRIDGETOWN, Barbados (AP) — Pop star Rihanna has given $1.75 million to a hospital in her Caribbean homeland of Barbados in memory of her late grandmother. Rihanna says the donation to buy three pieces of medical equipment was her way "giving back to Barbados." She made the comments during a Saturday ceremony with relatives at the island's Queen Elizabeth Hospital. The hospital's radiotherapy unit has been renamed the Clara Braithwaite Center for Oncology and Nuclear Medicine after Rihanna's grandmother, who died in June. Rihanna recently released "Unapologetic," her seventh album in seven years.
Read More..

Analysis: Apple's swoon exposes risk lurking in mutual funds

The nearly 28 percent decline in shares of Apple Inc since mid-September isn't just painful to individual shareholders. It's also being felt by investors who chased hot mutual funds that loaded up on Apple as the stock raced to a record $705 per share. Apple makes up 10 percent or more of assets in 117 out of the 1,119 funds that own its shares, according to data from Lipper, a Thomson Reuters company. Those big stakes have contributed positively to each fund's annual performance to date, with Apple still up about 32 percent for the year. It was trading at $527.73 soon after the opening on Friday. But that year-to-date outcome may not accurately reflect the performance of the funds for individual investors. All told, approximately $4.5 billion has been added to funds with overweight stakes in Apple this year, according to Morningstar data. The majority of these dollars were invested after March and after Apple first exceeded $600 per share - meaning many investors have been riding down with the decline. The $302 million Matthew 25 fund, for instance, holds 17.4 percent of its assets in Apple, according to Lipper. The fund's 31.9 percent gain through Thursday makes it one of the top performing funds for the year. Most of its Apple shares were bought years ago at a bargain basement price of about $125 per share. But $158.9 million of the fund's assets - or 53 percent - were invested after the end of March, when Apple was trading near $615 per share, according to Morningstar data. For those investors that bought after March, all that concentration in Apple hasn't led to a stellar gain but rather a drag on the portfolio. Someone who invested in Matthew 25 in early April has seen the value of the fund's Apple stake fall about 19 percent, while someone who invested at the beginning of September has watched that outsized Apple stake drop 27.2 percent. In turn, the majority of the fund's investors have reaped a much more modest performance than its year-end numbers suggest. Since the end of March, the fund has gained 6.7 percent, according to Morningstar data, far less than its 31 percent year-to-date gain and about two percentage points more than the benchmark Standard & Poor's 500 index. Since, September the fund is down nearly 3 percent through Thursday's close, compared with a 1.1 percent decline in the S&P 500 in that period. The impact of Apple's falling stock price shows some of the drawbacks of portfolio concentration, experts say. These stakes can leave the funds overexposed to the ups and downs of one company - counter to what most mutual funds are supposed to do for investors. "Any time you get over 10 percent of the portfolio in one company it's a red flag," said Michel Herbst, director of active fund research at Morningstar. Many fund managers do have risk management rules that prevent them from devoting more than 5 percent to 6 percent of their portfolio to any one stock, he said. Then again, some funds purposely invest in just a few stocks. Mark Mulholland, the portfolio manager of the Matthew 25 fund, said that taking concentrated positions in companies is the only way to beat an index over longer periods of time. 'RIGHT-SIZING' PORTFOLIOS Along with concerns about iPhone sales in China and tax-motivated selling among people who want to avoid potentially higher capital gains taxes in 2013, the wide fund ownership of Apple may be a factor in the size of the stock's recent declines, fund managers said. In addition, with so many funds already heavily invested in the high-priced stock, there may be fewer marginal buyers available to push prices up again when shares begin to dip. "The stock didn't go from $700 to $520 because people didn't like the new iPad. It's become a favorite short of hedge funds because they know they can get in on this," said Mark Spellman, a portfolio manager of the $300 million Value Line Income and Growth fund with a small position in Apple. Short interest in the stock rose to 20.6 million shares at the end of November from 15.1 million shares at the end of September, according to Nasdaq. "Some of my competitors have 12 percent of their assets in Apple, which I think is ludicrous", said Spellman, who said the company is no longer trading on its fundamentals. Sandy Villere, who has a 2.5 percent weighting of Apple in his $276 million Villere Balanced fund, said that some mutual fund managers are selling shares because of the over-weighting. "Right now many people who did take huge overweight positions are right-sizing their portfolios to get it in line with their regular weightings," he said. Still, some bullish investors see the stock's recent declines as a buying opportunity. Mulholland, the Matthew 25 portfolio manager, continues to say that shares should be priced at over $1,000 per share based on his valuation of the company at 10 times enterprise value divided by earnings before interest, taxes, depreciation and amortization (EBITDA). Apple trades at about 7 times that figure now. Wall Street analysts' average price target as of Thursday is $742.56, according to Thomson Reuters data. But Mulholland is happy to be more bullish than his peers. "I'm glad that I'm able to get it at these prices," he said.
Read More..

ICE to buy NYSE Euronext for $8.2 bln

REUTERS - In October, Jeff Sprecher, chief executive of upstart IntercontinentalExchange , approached NYSE Euronext CEO Duncan Niederauer with a modest proposal to team up on clearing trades in London. As the men continued talking, Sprecher grew bolder, instead suggesting that ICE buy NYSE in what became an $8.2 billion deal announced on Thursday. The deal will link up two powerful derivatives exchange and clearing house operators, but threatens to further reduce the clout of the New York Stock Exchange. While the New York Stock Exchange has stood for 200 years as an iconic symbol of U.S. capitalism, it is almost an afterthought in this deal. For ICE, the crown jewel of NYSE Euronext is Liffe, Europe's second-largest derivatives market, analysts said. Niederauer had long felt that NYSE's shareholders did not appreciate the true value of the London-based futures and options exchange, and had talked to bankers about how to improve NYSE's stock price, a person familiar with the matter said. Liffe will help ICE compete against U.S.-based CME Group, owner of the Chicago Board of Trade. Derivatives trading remains highly profitable for the exchanges, and new rules next year will dramatically expand the demand for clearing over-the-counter contracts. The stock market businesses are less valuable to ICE. The company said it will try to spin off the Euronext European stock market businesses in a public offering, generating speculation it may also have little interest in the NYSE trading floor. Profits from stock trading have been significantly eroded by new technology and the rise of other places for investors to trade, including venues known as "dark pools." ICE's Sprecher will be CEO of the combined organization, and the NYSE Euronext CEO will be president, a ceremonial title at many U.S. companies. In an interview, Niederauer said he would remain at least through 2014 as an "important senior member" of Sprecher's management team. Niederauer will also be CEO of the NYSE Group. The combined company will be based in New York and Atlanta, where ICE is headqurtered. Sprecher and Niederauerhave been friends for years, but the two stopped talking for about six weeks in 2011 when ICE teamed up with Nasdaq OMX Group to make an unsolicited bid for NYSE Euronext. That bid came even as the New York Stock Exchange operator was trying to sell itself to Deutsche Bourse . Regulatory concerns killed both deals. Without the Nasdaq or Deutsche Bourse's huge equity operations, ICE alone has far less overlapping business and should face easy approvals, antitrust lawyers said. The deal values each NYSE Euronext share at $33.12, a 28 percent premium to the stock's closing price on Wednesday. NYSE Euronext stock rose 34 percent to end at $32.25 on Thursday. ICE's shares fell as much as 4 percent but finished regular trading at $127.60, up 1.4 percent on the day. ICE said it would pay annual dividends of $300 million to the companies' shareholders once the deal closes, about what NYSE pays its shareholders now. IN THE DOLDRUMS The deal reflected Niederauer's inability to get his company's share price out of the doldrums. Before the latest ICE offer emerged, NYSE Euronext's shares had fallen by nearly a third since ICE and Nasdaq launched their thwarted joint bid. Further consolidation of exchanges was "inevitable" and ICE was a "great partner," Niederauer said on a call with analysts, so continuing on alone did not make sense. "We can sit here and keep slugging away and keep working hard, but the bottom line is we had not delivered, in my mind, sufficient returns to shareholders," Niederauer said. NYSE bought Euronext, including Liffe, for 8 billion euros in 2007. Sprecher incorporated the stalled stock price - and the unrecognized value of Liffe - as part of his pitch. "The reason that we were prepared to pay $33 a share for a company that was trading at $24 a share was that there is a $33 company in here and the market was just not either seeing it or willing to give credit for," he said in an interview. "We said, 'let's just force the credit.'" The two sides negotiated in secret for about eight to 10 weeks, the two CEOs said. In options markets, there were some signs that word might have leaked out, with a sudden upswing in the demand for call options on NYSE, which perform well when a company's share price rises. ICE started out as an online marketplace for energy trading before Sprecher initiated a string of acquisitions from the London-based International Petroleum Exchange in 2001, to the New York Board of Trade and, most recently, a handful of smaller deals, including a climate exchange and a stake in a Brazilian clearing house. ICE's current main operations are in energy futures trading and, it has steered clear of stocks and stock-options trading, key businesses for NYSE Euronext. "This deal is probably not going to generate a lot of concern from an antitrust perspective," said Warren Rosborough, a veteran of the U.S. Justice Department's antitrust division who is now with the law firm McDermott Will & Emery. In clearing, ICE has a popular U.S. over-the-counter and listed business, while Liffe's operation is strong in futures and based in Europe. Concerns over a small amount of competing derivatives business could be addressed with straightforward divestitures, Rosborough said. "It's an open question about whether it will generate questions," he added. "If there is a fix, it will be relatively easy fix." Sprecher said the deal had been "well received" by regulators after he and Niederauer completed a "whirlwind tour" in the United States and Europe ahead of Thursday's announcement. Officials at the European Commission, the Department of Justice and Securities and Exchange Commission declined to comment. Last year, Justice Department objections blocked ICE and Nasdaq OMX's $11 billion bid on concerns the tie-up would dominate U.S. stock listings. The rival $9.3 billion bid by Deutsche Boerse fell afoul of European regulators. A combined ICE-NYSE Euronext would leap-frog Deutsche Boerse to become the world's third-largest exchange group with a combined market value of $15.2 billion. CME Group has a market value of $17.5 billion, Thomson Reuters data shows. Hong Kong Exchanges and Clearing is the world's largest exchange group with a market cap of $19.5 billion. ICE said it expected to achieve $450 million in cost savings from the takeover. In the first year after the deal closes, additional earnings of 15 percent are expected. Long-time Wall Street traders saw the potential takeover of the venerable stock exchange by a 12-year-old derivatives upstart as fraught with symbolism. "It's the end of an era," said a director on the board of a rival exchange who did not have clearance to speak to the press and asked not to be named. "I think ultimately the floor will be closed, because Jeff (Sprecher) has shut every floor he's ever had," the person said. With the deal still a long way from completed, Sprecher and Niederauer said they planned to keep the high-profile NYSE trading floor running. "The floor has value and in particular, it has a lot of brand value," Niederauer said. "So we are committed. Jeff is committed." The exchange was prepared to shut down the floor temporarily during superstorm Sandy and trade completely electronically, Wall Street executives said. Shareholders will have the option of accepting $33.12 in cash per NYSE Euronext share or 0.2581 ICE share or a mix of $11.27 in cash and 0.1703 ICE share, subject to a maximum cash consideration of $2.7 billion. Morgan Stanley was the lead financial adviser to ICE, with assistance from BMO Capital Markets Corp, Broadhaven Capital Partners, JPMorgan Chase & Co , Lazard Group LLC , Societe Generale Corporate & Investment Banking, and Wells Fargo Securities LLC . ICE legal advisers are Sullivan & Cromwell LLP and Shearman & Sterling LLP. The main financial advisers to NYSE Euronext are Perella Weinberg Partners and BNP Paribas. Further financial advice to NYSE Euronext was provided by Blackstone Advisory Partners, Citigroup , Goldman Sachs & Co. and Moelis & Co. Legal advisers to NYSE Euronext are Wachtell, Lipton, Rosen & Katz, Slaughter & May, and Stibbe NV.
Read More..

Wall Street bounces back on hope for "cliff' solution

NEW YORK (Reuters) - U.S. stocks rebounded from early losses on Thursday after Republican House Speaker John Boehner said he would keep working on a solution to the "fiscal cliff" while also slamming President Barack Obama's approach to budget talks. NYSE Euronext was the S&P 500's biggest gainer, surging 34 percent to $32.25 after IntercontinentalExchange Inc said it would buy the operator of the New York Stock Exchange for $8.2 billion. ICE shares shot up 1.4 percent to $130.10. Republicans in the U.S. House of Representatives pushed ahead with their own plan to avoid a series of steep tax hikes and spending cuts due in early 2013, complicating negotiations with the White House. Obama has vowed to veto the plan. Investors have hoped for an agreement soon between policymakers, but progress has been slow. Boehner said he expected to continue to work with Obama, but repeated his charge that the president and Senate Democrats were trying to "slow walk" the country over the fiscal cliff. "Speaker Boehner went on the air and basically told us he doesn't like what the president's doing or not doing, and the markets rallied on that, which was kind of weird," said Stephen Guilfoyle, a trader at Meridian Equity Partners, in New York. The Dow Jones industrial average <.dji> gained 59.75 points, or 0.45 percent, to 13,311.72 at the close. The S&P 500 <.spx> rose 7.88 points, or 0.55 percent, to 1,443.69. The Nasdaq Composite <.ixic> climbed 6.02 points, or 0.20 percent, to 3,050.39. Stocks rallied earlier in the week on signs of progress in the fiscal cliff negotiations. But with the S&P 500 up 14.8 percent so far this year, investors are taking the opportunity to engage in some hedging as 2012 comes to a close. Herbalife lost 9.6 percent to $33.74 following news that hedge fund manager Bill Ackman was betting against the company as part of his big end-of-the-year short. The S&P Financial Index <.gspf> gained 1.4 percent. The U.S. economy grew 3.1 percent in the third quarter, faster than previously estimated, while the number of Americans filing new claims for jobless benefits rose more than expected in the latest week. Existing home sales jumped 5.9 percent in November, more than expected, and by the fastest monthly pace in three years. An index of housing shares <.hgx> gained 0.78 percent. But KB Home slid 6.4 percent to $15.60 as the company reported higher homebuilding costs and expenses in the fourth quarter. About 6.4 billion shares changed hands on the New York Stock Exchange, the Nasdaq and NYSE MKT, roughly in line with the daily average so far this year of about 6.46 billion shares. On the NYSE, advancers outnumbered decliners by a ratio of about 2 to 1. On the Nasdaq, five stocks rose for every three that fell.
Read More..

Regulator plans to sanction JPMorgan on "Whale" trade - report

(Reuters) - A U.S. bank regulator is planning to issue a formal action against JPMorgan Chase & Co , demanding that the bank fix lapses in risk controls that allowed some of its traders to build a risky bet that lost $6.2 billion, the Wall Street Journal reported on Thursday. The Office of the Comptroller of the Currency, a division of the Treasury Department that oversees banks, is not expected to levy a fine, but it does plan to issue an enforcement action, the Journal reported, citing unnamed people familiar with the matter. It would be the first regulatory sanction stemming from the high-profile trading debacle at JPMorgan, which happened in its London office. Bruno Iskil, a trader involved with the bet, earned the nickname "London Whale" because of the huge position he and his colleagues had been built using complex derivatives.
Read More..

ICE to buy NYSE Euronext for $8.2 billion

REUTERS - In October, Jeff Sprecher, chief executive of upstart IntercontinentalExchange , approached NYSE Euronext CEO Duncan Niederauer with a modest proposal to team up on clearing trades in London. As the men continued talking, Sprecher grew bolder, instead suggesting that ICE buy NYSE in what became an $8.2 billion deal announced on Thursday. The deal will link up two powerful derivatives exchange and clearing house operators, but threatens to further reduce the clout of the New York Stock Exchange. While the New York Stock Exchange has stood for 200 years as an iconic symbol of U.S. capitalism, it is almost an afterthought in this deal. For ICE, the crown jewel of NYSE Euronext is Liffe, Europe's second-largest derivatives market, analysts said. Niederauer had long felt that NYSE's shareholders did not appreciate the true value of the London-based futures and options exchange, and had talked to bankers about how to improve NYSE's stock price, a person familiar with the matter said. Liffe will help ICE compete against U.S.-based CME Group, owner of the Chicago Board of Trade. Derivatives trading remains highly profitable for the exchanges, and new rules next year will dramatically expand the demand for clearing over-the-counter contracts. The stock market businesses are less valuable to ICE. The company said it will try to spin off the Euronext European stock market businesses in a public offering, generating speculation it may also have little interest in the NYSE trading floor. Profits from stock trading have been significantly eroded by new technology and the rise of other places for investors to trade, including venues known as "dark pools." ICE's Sprecher will be CEO of the combined organization, and the NYSE Euronext CEO will be president, a ceremonial title at many U.S. companies. In an interview, Niederauer said he would remain at least through 2014 as an "important senior member" of Sprecher's management team. Niederauer will also be CEO of the NYSE Group. The combined company will be based in New York and Atlanta, where ICE is headqurtered. Sprecher and Niederauerhave been friends for years, but the two stopped talking for about six weeks in 2011 when ICE teamed up with Nasdaq OMX Group to make an unsolicited bid for NYSE Euronext. That bid came even as the New York Stock Exchange operator was trying to sell itself to Deutsche Bourse . Regulatory concerns killed both deals. Without the Nasdaq or Deutsche Bourse's huge equity operations, ICE alone has far less overlapping business and should face easy approvals, antitrust lawyers said. The deal values each NYSE Euronext share at $33.12, a 28 percent premium to the stock's closing price on Wednesday. NYSE Euronext stock rose 34 percent to end at $32.25 on Thursday. ICE's shares fell as much as 4 percent but finished regular trading at $127.60, up 1.4 percent on the day. ICE said it would pay annual dividends of $300 million to the companies' shareholders once the deal closes, about what NYSE pays its shareholders now. IN THE DOLDRUMS The deal reflected Niederauer's inability to get his company's share price out of the doldrums. Before the latest ICE offer emerged, NYSE Euronext's shares had fallen by nearly a third since ICE and Nasdaq launched their thwarted joint bid. Further consolidation of exchanges was "inevitable" and ICE was a "great partner," Niederauer said on a call with analysts, so continuing on alone did not make sense. "We can sit here and keep slugging away and keep working hard, but the bottom line is we had not delivered, in my mind, sufficient returns to shareholders," Niederauer said. NYSE bought Euronext, including Liffe, for 8 billion euros in 2007. Sprecher incorporated the stalled stock price - and the unrecognized value of Liffe - as part of his pitch. "The reason that we were prepared to pay $33 a share for a company that was trading at $24 a share was that there is a $33 company in here and the market was just not either seeing it or willing to give credit for," he said in an interview. "We said, 'let's just force the credit.'" The two sides negotiated in secret for about eight to 10 weeks, the two CEOs said. In options markets, there were some signs that word might have leaked out, with a sudden upswing in the demand for call options on NYSE, which perform well when a company's share price rises. ICE started out as an online marketplace for energy trading before Sprecher initiated a string of acquisitions from the London-based International Petroleum Exchange in 2001, to the New York Board of Trade and, most recently, a handful of smaller deals, including a climate exchange and a stake in a Brazilian clearing house. ICE's current main operations are in energy futures trading and, it has steered clear of stocks and stock-options trading, key businesses for NYSE Euronext. "This deal is probably not going to generate a lot of concern from an antitrust perspective," said Warren Rosborough, a veteran of the U.S. Justice Department's antitrust division who is now with the law firm McDermott Will & Emery. In clearing, ICE has a popular U.S. over-the-counter and listed business, while Liffe's operation is strong in futures and based in Europe. Concerns over a small amount of competing derivatives business could be addressed with straightforward divestitures, Rosborough said. "It's an open question about whether it will generate questions," he added. "If there is a fix, it will be relatively easy fix." Sprecher said the deal had been "well received" by regulators after he and Niederauer completed a "whirlwind tour" in the United States and Europe ahead of Thursday's announcement. Officials at the European Commission, the Department of Justice and Securities and Exchange Commission declined to comment. Last year, Justice Department objections blocked ICE and Nasdaq OMX's $11 billion bid on concerns the tie-up would dominate U.S. stock listings. The rival $9.3 billion bid by Deutsche Boerse fell afoul of European regulators. A combined ICE-NYSE Euronext would leap-frog Deutsche Boerse to become the world's third-largest exchange group with a combined market value of $15.2 billion. CME Group has a market value of $17.5 billion, Thomson Reuters data shows. Hong Kong Exchanges and Clearing is the world's largest exchange group with a market cap of $19.5 billion. ICE said it expected to achieve $450 million in cost savings from the takeover. In the first year after the deal closes, additional earnings of 15 percent are expected. Long-time Wall Street traders saw the potential takeover of the venerable stock exchange by a 12-year-old derivatives upstart as fraught with symbolism. "It's the end of an era," said a director on the board of a rival exchange who did not have clearance to speak to the press and asked not to be named. "I think ultimately the floor will be closed, because Jeff (Sprecher) has shut every floor he's ever had," the person said. With the deal still a long way from completed, Sprecher and Niederauer said they planned to keep the high-profile NYSE trading floor running. "The floor has value and in particular, it has a lot of brand value," Niederauer said. "So we are committed. Jeff is committed." The exchange was prepared to shut down the floor temporarily during superstorm Sandy and trade completely electronically, Wall Street executives said. Shareholders will have the option of accepting $33.12 in cash per NYSE Euronext share or 0.2581 ICE share or a mix of $11.27 in cash and 0.1703 ICE share, subject to a maximum cash consideration of $2.7 billion. Morgan Stanley was the lead financial adviser to ICE, with assistance from BMO Capital Markets Corp, Broadhaven Capital Partners, JPMorgan Chase & Co , Lazard Group LLC , Societe Generale Corporate & Investment Banking, and Wells Fargo Securities LLC . ICE legal advisers are Sullivan & Cromwell LLP and Shearman & Sterling LLP. The main financial advisers to NYSE Euronext are Perella Weinberg Partners and BNP Paribas. Further financial advice to NYSE Euronext was provided by Blackstone Advisory Partners, Citigroup , Goldman Sachs & Co. and Moelis & Co. Legal advisers to NYSE Euronext are Wachtell, Lipton, Rosen & Katz, Slaughter & May, and Stibbe NV. (Additional reporting by Luke Jeffs and David Brough in London, Jessica Toonkel, Jed Horowitz, Jonathan Spicer, David Gaffen and Karen Brettell in New York, Sarah N. Lynch and Diane Bartz in Washington and Ann Saphir in Chicago; writing by Carmel Crimmins and Aaron Pressman; Editing by
Read More..

Trafigura 2012 earnings fall below $1 bln - FT

SINGAPORE, Dec 21 (Reuters) - Commodities trader Trafigura earned about $1 billion for the second straight year in 2012, but down from a record achieved last year due to higher staff costs and new investments, the Financial Times reported. The privately-held company, based in Geneva and Singapore, made a profit of $991.9 million in the year to September, down 11 percent from last year's record $1.11 billion, the FT said, citing data from Trafigura's annual report. The commodities trader's profits show that the profitability of the world's top houses that dominate raw materials trade is strong despite slower economic growth in top consumer China. The drop from 2011 was due to higher staff costs and expenses related to new investments and business purchases, the FT reported. Gross profit, a rough measure of underlying profitability, was up on the year. Revenues fell 1.6 percent to $120 billion, it said. The company does not release its accounts publicly.
Read More..

ICE to acquire NYSE in $8.2bn deal

London, Dec. 21 (ANI): IntercontinentalExchange (ICE), the 12-yr old firm dealing in contracts tied to energy and commodity prices, has agreed to buy NYSE Euronext for cash and stock in a deal worth 8.2 billion dollars. As part of the deal, ICE also gains control of the Liffe (London International Financial Futures and Options Exchange) and stock exchanges in Paris, Lisbon, Brussels and Amsterdam. However, Liffe, an exchange through which investors can make bets on the future level of interest rates, is estimated to generate about 40pc of profits at NYSE, The Telegraph reports. According to the paper, ICE said it would merge Liffe with ICE Clear Europe, its London-based business that clears derivatives trades once they are agreed. "Liffe is the crown jewel in NYSE Euronext. It is a sign that exchanges are very interested in expanding in London," said Richard Perrott, an analyst at Berenberg Bank. The deal will see ICE pay NYSE investors 33.12 dollars for each of their shares, 38pc higher than the price they closed at on Wall Street on Wednesday night, the paper said.
Read More..

NHL lockout has chilling effect on business

BUFFALO, N.Y. (AP) — Most everywhere Lou Billittier turns these days, the Buffalo restaurateur is reminded of the NHL  lockout, and its impact on his blue-collar, sports-mad town where Dominik Hasek became a star and the French Connection is still revered.

Billittier misses the familiar faces of Sabres players having their traditional game-day lunch at his restaurant, Chef's. He recalled a recent conversation he had with his seafood supplier, who's struggling because he also provides salmon and chicken wings to the Sabres arena, the First Niagara Center.

And then there are the arena's idled, part-time employees who stop in looking for work. With his own business down 15 percent, Billittier can only turn them away because he's concerned whether there's enough work for his staff.

"It's amazing the trickle-down effect," Billittier said, standing in his lobby, not far from Chef's "The French Connection" room, honoring the famed former Sabres line of Gilbert Perreault, Rene Robert and Rick Martin. "It bothers me, not only because we're down, but it affects everything. Our community out-reach, we can't donate to the people we normally donate to. It's brutal."

From south Florida to Vancouver, Montreal to Anaheim, a wide array of businesses located in the NHL's 30 markets have taken a significant hit because of the lockout, which is now in its fourth month and has wiped away 625 games. On Thursday, the league canceled all games through Jan. 14.

Joe Kasel, owner of the Eagle Street Grille in St. Paul, Minn., last month wrote a letter expressing his concerns to NHL Commissioner Gary Bettman.

"I had to look 32 of 48 employees in the eyes and inform them that I no longer can afford to keep them on staff," Kasel wrote. "The impact on our lives is immeasurable. One city's devastation may not seem like a powerful incentive to end the lockout; but I know this is happening in other cities around the nation."

Chris Ray, manager of the Brewhouse Downtown in Nashville, said his establishment is losing an estimated $5,000 for every canceled Predators' home game. That's already a $90,000 hit, given 18 Predators' home games have been wiped out.

It's no different at Wayne Gretzky's sports bar in Toronto, where much of the Great One's memorabilia is on display.

"Yes, it's been very slow," said a bartender, who wouldn't give her name. "I'm scared about January."

The Hockey Hall of Fame in Toronto is feeling the pinch. Hall of Fame spokeswoman Kelly Masse said they've made "adjustments" to staff because gate and retail revenues are down significantly.

And so's Hockeytown, aka, Detroit.

The downtown three-level Hockeytown Cafe, operated by Red Wings owner Mike Ilitch, was nearly empty on Monday.

"If there's not a show at the Fox, this is what it's like in here," bartender Molly Brown said, referring to the Fox Theatre next door. "We haven't fired anyone, but everyone has had their days and hours cut because the Red Wings aren't playing. We're all suffering."

The effect goes beyond bars, restaurants and tourism.

In Chicago, Gunzo's Hockey Headquarters, a four-store chain that sells hockey equipment and jerseys, is losing business.

"It's been a huge impact. Huge, huge, huge. People don't see the games and it's out of sight, out of mind," owner Keith Jackson said. "It's kind of a double-whammy for us. We're losing out on equipment sales and we're losing out on the jerseys and licensed apparel sales."

With the Christmas shopping season nearly over, Jackson worries those are sales he'll never get back even if the NHL resumes playing soon. Mid-January will be a critical time, since Bettman has said the league doesn't want to play a season shorter than 48 games per team.

With an entire season wiped out in 2004-05, outsiders are wondering whether the two sides — rich owners and well-paid players — are indifferent to the effects their labor disputes create.

"People are disgusted," said Tom Woolsey, owner of Andrews On the Corner in Detroit. He estimates his business is down 75 percent on nights the Red Wings are playing.

"It's incomprehensible to me that after four or five prosperous years in the NHL, that they can't figure out how to split $3.2 billion (in revenue)," Woolsey said.

It's mind-boggling to John Heidinger, chairman of the Service Employees International Local 200 in Buffalo, who represents about 225 ushers at First Niagara Center.

"When you're making 12 bucks an hour working at an arena, and these guys are haggling over hundreds of millions of dollars, I think for a lot of people it's a hard reality to understand," Heidinger said. "It really frustrates you."

Sabres president Ted Black can understand the frustration.

"We are disappointed the NHL and NHLPA have not been able to negotiate a new collective bargaining agreement," Black said. "Our fans are extremely disappointed, and we know the lack of NHL hockey is having a negative impact on many local businesses. At the same time, we want to play hockey under the right circumstances that the NHL will negotiate on our behalf. ... The league has our full confidence."

The impact of another lost season would be high.

In Buffalo alone, the city's tourism bureau, Visit Buffalo Niagara, estimates local hotels that host visiting NHL teams will lose between $850,000 and $1 million if there's no season.

City transit is affected. Douglas Hartmayer, spokesman for the Niagara Frontier Transportations Authority, says up to 1,700 riders use Metro Rail to attend each Sabres home game.

There's even a psychological cost, especially in a place like Buffalo, where the winters are already long, and the Sabres provide an entertaining outlet, particularly when the Buffalo Bills are struggling, as they are once again are this year.

"Especially with Pegula, you had some hope," said Joe Allman, bartender at the Swannie House, referring to Sabres owner Terry Pegula, who's raised expectations since purchasing the team two years ago. "They probably are our best chance to win."

With no hockey, and the Bills out of playoff contention for a 13th straight season, there's little for Buffalonians to fall back on.
Read More..

Barring setback, Redskins' RG3 looks good to go

    *

      Kirk Cousins will start in place of Griffin wgho is sitting out with a sprained knee. (AP Photo/Rick Osentoski)  less

ASHBURN, Va. (AP) — Robert Griffin III looks good to go.

The Washington Redskins rookie had a full practice Thursday for the second straight day as the team prepares for this week's game against the Philadelphia Eagles.

"I like what I see," coach Mike Shanahan said. "If there is no setback, he should be ready to go."

Griffin missed Sunday's win over the Cleveland Browns with a sprained right knee. On Wednesday, he had his first full practice since the injury, and coaches and doctors were eager to see how the knee would respond.

"There wasn't a setback today, so that's a good sign," Shanahan said.

Also Thursday, right tackle Tyler Polumbus remained unable to practice as he recovers from a concussion. Linebacker London Fletcher (sprained left ankle), linebacker Lorenzo Alexander (right shoulder) and defensive end Stephen Bowen (torn biceps) were limited, and linebacker Rob Jackson returned to practice after the birth of his baby girl.
Read More..

AP IMPACT: Steroids loom in major-college football

WASHINGTON (AP) — With steroids easy to buy, testing weak and punishments inconsistent, college football  players are packing on significant weight — 30 pounds or more in a single year, sometimes — without drawing much attention from their schools or the NCAA in a sport that earns tens of billions of dollars for teams.

Rules vary so widely that, on any given game day, a team with a strict no-steroid policy can face a team whose players have repeatedly tested positive.

An investigation by The Associated Press — based on interviews with players, testers, dealers and experts and an analysis of weight records for more than 61,000 players — revealed that while those running the multibillion-dollar sport say they believe the problem is under control, that control is hardly evident.

The sport's near-zero rate of positive steroids tests isn't an accurate gauge among college athletes. Random tests provide weak deterrence and, by design, fail to catch every player using steroids. Colleges also are reluctant to spend money on expensive steroid testing when cheaper ones for drugs like marijuana allow them to say they're doing everything they can to keep drugs out of football.

"It's nothing like what's going on in reality," said Don Catlin, an anti-doping pioneer who spent years conducting the NCAA's laboratory tests at UCLA. He became so frustrated with the college system that it was part of the reason he left the testing industry to focus on anti-doping research.

___

EDITOR'S NOTE — Whether for athletics or age, Americans from teenagers to baby boomers are trying to get an edge by illegally using anabolic steroids and human growth hormone, despite well-documented risks. This is the first of a two-part series.

___

While other major sports have been beset by revelations of steroid use, college football has operated with barely a whiff of scandal. Between 1996 and 2010 — the era of Barry Bonds, Mark McGwire, Marion Jones and Lance Armstrong — the failure rate for NCAA steroid tests fell even closer to zero from an already low rate of less than 1 percent.

The AP's investigation, drawing upon more than a decade of official rosters from all 120 Football Bowl Subdivision teams, found thousands of players quickly putting on significant weight, even more than their fellow players. The information compiled by the AP included players who appeared for multiple years on the same teams.

For decades, scientific studies have shown that anabolic steroid use leads to an increase in body weight. Weight gain alone doesn't prove steroid use, but very rapid weight gain is one factor that would be deemed suspicious, said Kathy Turpin, senior director of sport drug testing for the National Center for Drug Free Sport, which conducts tests for the NCAA and more than 300 schools.

Yet the NCAA has never studied weight gain or considered it in regard to its steroid testing policies, said Mary Wilfert, the NCAA's associate director of health and safety.

The NCAA attributes the decline in positive tests to its year-round drug testing program, combined with anti-drug education and testing conducted by schools.

The AP's analysis found that, regardless of school, conference and won-loss record, many players gained weight at exceptional rates compared with their fellow athletes and while accounting for their heights.

Adding more than 20 or 25 pounds of lean muscle in a year is nearly impossible through diet and exercise alone, said Dan Benardot, director of the Laboratory for Elite Athlete Performance at Georgia State University.

In nearly all the rarest cases of weight gain in the AP study, players were offensive or defensive linemen, hulking giants who tower above 6-foot-3 and weigh 300 pounds or more. Four of those players interviewed by the AP said that they never used steroids and gained weight through dramatic increases in eating, up to six meals a day. Two said they were aware of other players using steroids.

"I ate 5-6 times a day," said Clint Oldenburg, who played for Colorado State starting in 2002 and for five years in the NFL. Oldenburg's weight increased over four years from 212 to 290.

Oldenburg told the AP he was surprised at the scope of steroid use in college football, even in Colorado State's locker room. "There were a lot of guys even on my team that were using." He declined to identify any of them.

The AP found more than 4,700 players — or about 7 percent of all players — who gained more than 20 pounds overall in a single year. It was common for the athletes to gain 10, 15 and up to 20 pounds in their first year under a rigorous regimen of weightlifting and diet. Others gained 25, 35 and 40 pounds in a season. In roughly 100 cases, players packed on as much 80 pounds in a single year.

In at least 11 instances, players that AP identified as packing on significant weight in college went on to fail NFL drug tests. But pro football's confidentiality rules make it impossible to know for certain which drugs were used and how many others failed tests that never became public.

Even though testers consider rapid weight gain suspicious, in practice it doesn't result in testing. Ben Lamaak, who arrived at Iowa State in 2006, said he weighed 225 pounds in high school. He graduated as a 320-pound offensive lineman and said he did it all naturally.

"I was just a young kid at that time, and I was still growing into my body," he said. "It really wasn't that hard for me to gain the weight. I love to eat."

In addition to random drug testing, Iowa State is one of many schools that have "reasonable suspicion" testing. That means players can be tested when their behavior or physical symptoms suggest drug use. Despite gaining 81 pounds in a year, Lamaak said he was never singled out for testing.

The associate athletics director for athletic training at Iowa State, Mark Coberley, said coaches and trainers use body composition, strength data and other factors to spot suspected cheaters. Lamaak, he said, was not suspicious because he gained a lot of "non-lean" weight.

But looking solely at the most significant weight gainers also ignores players like Bryan Maneafaiga.

In the summer of 2004, Bryan Maneafaiga was an undersized 180-pound running back trying to make the University of Hawaii football team. Twice — once in pre-season and once in the fall — he failed school drug tests, showing up positive for marijuana use but not steroids.

He'd started injecting stanozolol, a steroid, in the summer to help bulk up to a roster weight of 200 pounds. Once on the team, he'd occasionally inject the milky liquid into his buttocks the day before games.

"Food and good training will only get you so far," he told the AP recently.

Maneafaiga's former coach, June Jones, said it was news to him that one of his players had used steroids. Jones, who now coaches at Southern Methodist University, believes the NCAA does a good job rooting out steroid use.

On paper, college football has a strong drug policy. The NCAA conducts random, unannounced drug testing and the penalties for failure are severe. Players lose an entire year of eligibility after a first positive test. A second offense means permanent ineligibility for sports.

In practice, though, the NCAA's roughly 11,000 annual tests amount to a fraction of all athletes in Division I and II schools. Exactly how many tests are conducted each year on football players is unclear because the NCAA hasn't published its data for two years. And when it did, it periodically changed the formats, making it impossible to compare one year of football to the next.

Even when players are tested by the NCAA, experts like Catlin say it's easy enough to anticipate the test and develop a doping routine that results in a clean test by the time it occurs. NCAA rules say players can be notified up to two days in advance of a test, which Catlin says is plenty of time to beat a test if players have designed the right doping regimen. By comparison, Olympic athletes are given no notice.

Most schools that use Drug Free Sport do not test for anabolic steroids, Turpin said. Some are worried about the cost. Others don't think they have a problem. And others believe that since the NCAA tests for steroids their money is best spent testing for street drugs, she said.

Doping is a bigger deal at some schools than others.

At Notre Dame and Alabama, the teams that will soon compete for the national championship, players don't automatically miss games for testing positive for steroids. At Alabama, coaches have wide discretion. Notre Dame's student-athlete handbook says a player who fails a test can return to the field once the steroids are out of his system.

The University of North Carolina kicks players off the team after a single positive test for steroids. Auburn's student-athlete handbook calls for a half-season suspension for any athlete caught using performance-enhancing drugs.

At UCLA, home of the laboratory that for years set the standard for cutting-edge steroid testing, athletes can fail three drug tests before being suspended. At Bowling Green, testing is voluntary.

At the University of Maryland, students must get counseling after testing positive, but school officials are prohibited from disciplining first-time steroid users.

Only about half the student athletes in a 2009 NCAA survey said they believed school testing deterred drug use. As an association of colleges and universities, the NCAA could not unilaterally force schools to institute uniform testing policies and sanctions, Wilfert said.

"We can't tell them what to do, but if went through a membership process where they determined that this is what should be done, then it could happen," she said.

___

Associated Press writers Ryan Foley in Cedar Rapids, Iowa; David Brandt in Jackson, Miss.; David Skretta in Lawrence, Kan.; Don Thompson in Sacramento, Calif., and Alexa Olesen in Shanghai, China, and researchers Susan James in New York and Monika Mathur in Washington contributed to this report.

___

Contact the Washington investigative team at DCinvestigations (at) ap.org.

Whether for athletics or age, Americans from teenagers to baby boomers are trying to get an edge by illegally using anabolic steroids and human growth hormone, despite well-documented risks. This is the first of a two-part series.

Read More..

It's official, Andersen is new Wisconsin coach

MADISON, Wis. (AP) — Several schools tried to lure Gary Andersen away from Utah State.

Wisconsin finally got him.

Andersen was officially hired as the Badgers' new coach Thursday, and will be formally introduced at a news conference Friday morning. He replaces Bret Bielema, who left the Badgers for Arkansas this month.

"I don't know if I can really have a word for how excited I am to be at Wisconsin and have this opportunity," Andersen said in a video on Wisconsin's website. "I know I'm humbled, I know I'm blessed."

The 48-year-old Andersen just completed his fourth and best season at Utah State. The 18th-ranked Aggies finished 11-2 with a bowl victory against Toledo and won the Western Athletic Conference. One of those losses was at Wisconsin, where the Aggies missed a 37-yard field goal in the final seconds to allow the Badgers to escape with a 16-14 win.

It's been a remarkable rise for a program that had been near the bottom of major college football for years, and stuck in distant third in its own state behind BYU and Utah. The Aggies won nine games in the previous four seasons before Andersen took over. The last football coach to finish his tenure in Logan, Utah, with a winning record was Phil Krueger who went 21-12 from 1973-75.

Andersen drew interest from California, Colorado and Kentucky last month, but decided to pass on those opportunities and received a contract extension from Utah State.

When Wisconsin called, however, Andersen couldn't resist.

"It all came together," he said in a video on Wisconsin's website. "By no means was I sitting out there going, 'I've got to have a job, I've got to have a job.' But as soon as this one popped open, to me, this was a special, special place."

Before Andersen left Logan, Utah, however, he called his players — all 107 of them — so they would hear the news that he was leaving from him and not on TV or Twitter.

"I couldn't tell them yet that I had taken the job," Andersen told UWBadgers.com. "But I told them if I was offered the job I was going to take the job. There were a bunch of tears and hard conversations."

Andersen replaces Bielema, who left Wisconsin on Dec. 4, three days after the Badgers routed Nebraska to win the Big Ten title and a school-record third straight trip to the Rose Bowl. Athletic director Barry Alvarez has agreed to coach Wisconsin in the bowl at the request of the players.

Though the Badgers' 8-5 record going into the Rose Bowl is their worst since 2008, Andersen is inheriting a team loaded with talent through Wisconsin will lose Montee Ball, who set the major college record for career touchdowns this year and tied the single-season mark last year, along with linebacker Mike Taylor and standout defensive backs Marcus Cromartie and Devin Smith.

The Badgers still have James White or Melvin Gordon, who rushed for a total of almost 1,400 yards and 15 touchdowns. Jared Abbrederis has led the Badgers in receiving each of the last two seasons, and Joel Stave showed promise before the freshman broke his collarbone. Disruptive linebacker Chris Borland, who is second with 4 1/2 sacks and 95 tackles despite missing two games, also is expected back.

And while this will be Andersen's first job in the Midwest, one Big Ten opponent has no doubt he can succeed. When Alvarez was considering Andersen, he called Ohio State coach Urban Meyer, who had Andersen on his staff at Utah in 2004, when the Utes went 12-0 and won the Fiesta Bowl.

"(Meyer has) had some very good assistants," Alvarez said on UWBadgers.com. "Urban told me that Gary is in the top five of all of them; he's the real deal. I said, 'Would he fit here? Would he fit in the Big Ten?' He said, 'Absolutely.'"

Read More..